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Mammalian Chimaeras. ANNE MCLAREN
(1976) Cambridge: Cambridge University
Press. 154 pp. Price £8.00 net.
Ten years ago, a scientific book with such
a title would have been unthinkable. A
" chimaera " was simply a mythical monster.
On page 1, McLaren gives a pretty exhaustive
list of these monsters.
But the mammalian chimaera of the
1970s is a different kettle of fish. It was
invented by Tarkowski in 1961, when he
fused cleavage-stage mouse eggs and trans-
planted them into foster mothers. Thus, he
raised mice with four parents and one foster
parent. It was a novelty comparable with
the contemporary production of somatic cell
hybrids in vitro, and similarly provides
opportunities for new kinds of biological
research, particularly in developmental gene-
tics. More recently (Gardner, 1968) there
has been a modification, with the injection
offew or single cells from disrupted eggs into
blastocysts, producing unequal chimaeras.
These reveal the potentiality of single cells
from differentiating embryos.
Strangely enough, since the production of
artificial chimaeras, it has been found that
they can arise, very rarely, spontaneously in
man. They seem to arise by double fertili-
sation (familiar to botanists). Unlike the
artificial chimaeras, therefore, they have 2
parents not 4, though 4 gametic genomes are
present.
Secondary chimaeras have the foreign
cells introduced at a later stage and tolerated,
either because the immune system has been
destroyed (radiation chimaeras) or has never
existed (nude mice) or has not yet developed
(in the foetus; e.g. twins in cattle, giving rise
to freemartins and blood chimaeras). This
definition would include the recipients of
kidney, heart and liver transplants, and
tumour transplants: but that is not the
concern of this book.
A distinction is made between chimaeras,
the merging oftwo individuals into one body,
and mosaics, produced from one zygote by
segregation. This distinction, while very
clear in theory, may be difficult to establish
in practice.
Fascinating though these topics are, it is
Chapter 8 which mainly concerns readers of
this Journal. This chapter presents the data
on chimaeras between mouse strains of high
and low cancer incidence. Such data should
decide whether these cancers arise through
the susceptible genotype of the cells, or as a
systemic effect.
Ifcancer proneness were a cell characteris-
tic, the chimaera would be expected to be
intermediate between the pure strains, and
the tumours would consist solely of cells from
the high-cancer strain. If the cancer pro-
neness were systemic, the tumour incidence
would be high or low, according to the
" dominance " of cancer proneness, and
either cell type would be present in the
tumour.
The results of 5 experiments indicate
neither of these expectations. In 4/5 cases
the chimaera has the same tumour incidence
as the high-cancer strain, but most of the
tumours are also ofthat strain. In every case,
the tissue affected by the tumour, whether
mammary gland, liver, lung or blood, is
mainly composed of the high-cancer strain
cells. It appears that cancer proneness in a
particular tissue is preceded by competitive
growth of the normal but cancer-prone cells
of that tissue, a property which, therefore,
appears to be a pre-cancerous condition.
On the other hand, the involvement of
cells from the low-cancer strain was higher
than expected in the pure strain. So there
was also a systemic effect. In one chimaera
only, between the lymphoma strain AKR
and the non-lymphoma strain CBA, was there
evidence of suppression of the tumour by
cells of the low-cancer strain.
This little monograph amply surveys the
current status of the fascinating topic of
chimaeras in mammals.
A. J. BATEMAN
Oncologic Medicine. Ed. A. I. SUTNICK
and P. F. ENGSTROM (1976). Baltimore:
University Park Press. 386 pp. Price
$24.50 (£5.50)
This volume has been published to mark
the 50th anniversary of the Institute for386 BOOK REVIEWS
Cancer Research of the Fox Chase Cancer
Centre, Philadelphia. It consists of a series
of essays relating to Medical Oncology. It
divides into 3 main sections; the first being a
series of reviews of aetiology, immunology
and epidemiology in cancer; the second,
essays and overviews on the treatment of
specific cancers; and the third is a group of
papers on " Supportive Care ", dealing with
all aspects of this, from infection to psycho-
social support.
The first section, covering only about
100 pages, is necessarily brief. Aetiology is
summarised in 2 short chapters dealing with
virology and immunosurveillance. There is
a useful summary of immunodiagnostic tests,
and their effectiveness and specificity, and
host defence is considered in relationship to
neuroblastoma and melanoma.
The chapters on treatment of specific
tumours vary. Lung, breast and testicular
cancer are dealt with in detail. In the
chapters on breast cancer by Creech and
Carbone, future approaches and prospective
studies are considered in a helpful and
constructive way.
There follows a series of overviews on the
management and detection of other cancers.
It is difficult to know whom these will help.
They are, in the main, so brief that the
practising oncologist will already be fully
aware of what they say, and they do not
contain the less specific information that a
medical student or nurse would be seeking.
They are the least satisfactory part of the
book.
The section on supportive care is much
better. The chapters are of adequate length
to deal with each aspect in detail, and
anaemia, haemostasis, infection and other
topics such as the skin manifestation of
cancer, and rehabilitation are discussed with
reference to clinical management. Whilst
other parts of the book relate specifically to
certain research projects at the Fox Chase
Cancer Centre, the 100 pages that comprise
the " Supportive Care " section are balanced
reviews, and published separately would be
an invaluable reference guide for any doctor
in clinical oncology.
" Oncologic Medicine " is, in summary, a
book about which it is impossible to be wholly
enthusiastic. It is not a textbook of medical
oncology. As an overall review it is lacking
in certain areas. Although the section on
supportive care is excellent, the price (£15.50)
will probably deter many from using it as
their standard reference.
G. BLACKLEDGE
Human Tumours in Short Term Culture:
Techniques and Clinical Applications.
Ed. P. P. DENDY (1976). London: Aca-
demic Press. 344 pp. Price £9.80.
This volume represents the proceedings
of a meeting in Cambridge, England in
September 1974. The science (or art?) of
culturing human tumour cells, and in
particular, their use for predictive tests of
in vivo response, is still in its infancy. Never-
theless, sufficient information has been
acquired by a number of groups actively
working in this field, to make this meeting
and subsequent publication of these pro-
ceedings very worthwhile. The contents
represent a large proportion of what is
currently known of cultured human tumour
cells.
The book is conveniently divided into
chapters on methodology, identification of
tumour as opposed to non-tumour cells,
effects of drugs, radiation and hormones,
immunological assays, and finally clinical
evaluation ofshort term tests. This division
makes it relatively easy to find papers on
specific topics, but the discussion on these
pages is more difficult to find.
The least satisfactory chapter is that
dealing with methodology, which would have
benefited from a brief introduction to the
various types of short term culture (e.g.
single cell, tissue slices), the separation of
methods of setting up cultures from those
used in in vitro assays, an explanation of the
rationale for some of the techniques, more
figures and diagrams and a critical appraisal
of the advantages and disadvantages of the
various methods described by different con-
tributors. Much of the methodology is
simply a repetition of what has been used for
manv years for animal tumours.
A basic premise on which in vitro human
tumour studies are based is that it is the
malignant cells which grow in culture. The
problems of demonstrating this and some of
the methods available are described. It is
good to see that the contributors have not
been reticent in pointing out the dangers of
assuming that, even when the cultured cells
are oftumour origin, they are a representative
sample of tumour cells in vivo. Many of the